What is the CVSS score of CVE-2024-38288?

CVE-2024-38288 has a CVSS 3.1 base score of 7.2 (High). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 3.2%.

Is there a public PoC exploit available for CVE-2024-38288?

Yes, a public proof-of-concept exploit is available for CVE-2024-38288. Prioritise patching immediately. EPSS: 3.2%.

Turbomeeting CVE-2024-38288

HIGH

Command Injection (CWE-77)

2024-07-25 cve@mitre.org

Command Injection Turbomeeting

7.2

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

7.2 HIGH

AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

High

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Jul 25, 2024 - 20:15 nvd

HIGH 7.2

DescriptionNVD

AnalysisAI

A command-injection issue in the Certificate Signing Request (CSR) functionality in R-HUB TurboMeeting through 8.x allows authenticated attackers with administrator privileges to execute arbitrary. Rated high severity (CVSS 7.2), this vulnerability is remotely exploitable, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified as Command Injection (CWE-77), which allows attackers to inject arbitrary commands into system command execution. A command-injection issue in the Certificate Signing Request (CSR) functionality in R-HUB TurboMeeting through 8.x allows authenticated attackers with administrator privileges to execute arbitrary commands on the underlying server as root. Affected products include: Rhubcom Turbomeeting. Version information: through 8..

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Use parameterized APIs, avoid shell execution, validate input with strict allowlists.